United Services Automobile Association Vericel Corp Transaction History

United Services Automobile Association

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$14.93 - $19.83 $4.11 Million - $5.46 Million	-275,243 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$15.01 - $18.89 $352,599 - $443,744	23,491 Added 9.33%	275,243 $5.2 Million
Q1 2019 May 13, 2019	SELL	$16.23 - $20.29 $255,005 - $318,796	-15,712 Reduced 5.87%	251,752 $4.41 Million
Q4 2018 Feb 13, 2019	BUY	$10.77 - $18.44 $152,503 - $261,110	14,160 Added 5.59%	267,464 $4.65 Million
Q3 2018 Nov 13, 2018	BUY	$9.1 - $14.8 $94,822 - $154,216	10,420 Added 4.29%	253,304 $3.58 Million
Q2 2018 Aug 10, 2018	BUY	$9.6 - $14.6 $2.33 Million - $3.55 Million	242,884 New	242,884 $2.36 Million

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.79B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.